Fatty acid remodelling of phosphatidylinositol under conditions of de novo synthesis in rat liver microsomes.
Phosphatidylinositol (PI) is initially synthesized in mammalian cells with a fatty acid composition similar to that of its precursor, primarily monounsaturated forms of cytidine diphosphodiglyceride (CDP-DAG). However, at the steady state, over 80% of PI exists in the 1-stearoyl, 2-arachidonoyl form. The fatty acid remodelling of PI is due to a number of deacylation/reacylation mechanisms. In the preceding paper we demonstrated that de novo synthesized PI is rapidly deacylated and subsequently reacylated. In this report we present further evidence that cycles of deacylation and reacylation are involved in the remodelling of PI. Incubation of microsomes with CDP-DAG of different fatty acid composition results in quantitative and qualitative differences in lysoPI formation. Additionally, analyses of the resulting lysoPI and PI species reveal that multiple species of fatty acids are incorporated into the 1-position of both PI and lysoPI. Addition of acylation cofactors (fatty acyl CoAs or ATP plus CoA) potentiate reacylation in this system. The addition of stearoyl or myristoyl CoA during de novo synthesis of PI results in the incorporation of these added fatty acids into the I-positive of PI. In addition, some evidence is presented that multiple mechanisms for remodelling of the 1-position of PI may be active in the microsomes, including ATP- and CoA-dependent acylation, ATP-independent, CoA-dependent acylation and CoA-independent mechanisms. Finally, the disappearance of only a subset of lysoPI species upon the addition of acylation cofactors suggests that the reacylation step exhibits some substrate specificity.
Darnell
J C
JC
Laboratory of Molecular Oncology, Rockefeller University, New York.
Osterman
D G
DG
Saltiel
A R
AR
D000214:Acyl Coenzyme A / Q000378:metabolism / Q000494:pharmacology; D000215:Acylation; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002384:Catalysis; D002855:Chromatography, Thin Layer; D003567:Cytidine Diphosphate Diglycerides / Q000737:chemistry; D004357:Drug Synergism; D004530:Egg Yolk / Q000032:analysis; D005227:Fatty Acids / Q000737:chemistry / Q000378:metabolism*; D008246:Lysophospholipids / Q000096:biosynthesis* / Q000737:chemistry; D008862:Microsomes, Liver / Q000378:metabolism*; D010716:Phosphatidylinositols / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism; D010740:Phospholipases / Q000378:metabolism; D051381:Rats
D000214:Acyl Coenzyme A; D003567:Cytidine Diphosphate Diglycerides; D005227:Fatty Acids; D008246:Lysophospholipids; D010716:Phosphatidylinositols; C025449:lysophosphatidylinositol; D000255:Adenosine Triphosphate; D010740:Phospholipases